Moyamoya disease and other forms of intracranial stenosis cause the progressive narrowing of vessels in the brain. This can cause transient ischemic attacks (TIAs) and stroke. Over time, patients may develop severe headaches, TIAs and strokes leading to neurological problems, including vision, speech, movement and sensation problems. Moyamoya can appear at any age. Although it is considered a rare disease, it is often misdiagnosed.
- Care at Milton S. Hershey Medical Center
- Groups, Classes & Support
- Research & Clinical Trials
- Symptoms, Diagnosis & Outlook
Care at Milton S. Hershey Medical Center
The treatment of moyamoya and intracranial stenosis begins with radiological studies to confirm the diagnosis and plan for treatment. Moyamoya patients are started on aspirin and asked to stay well hydrated. The definitive treatment for moyamoya is direct cerebral bypass. This surgery dramatically reduces the risk of stroke. Patients can go on to live normal, healthy lives following direct cerebral bypass. This surgery dramatically reduces the risk of stroke in moyamoya patients.
Patients are evaluated and treated in our Cerebral Revascularization Program in the Department of Neurosurgery. The Penn State Cerebral Revascularization Program is one of a few programs in the country that specialize in the treatment of moyamoya with direct bypass.
Patients are seen at our neurosurgery outpatient clinic at 30 Hope Drive, Hershey, PA. Surgeries are performed at the Medical Center at 500 University Drive, Hershey, PA.
Research & Clinical Trials
One of the goals of the Penn State Cerebral Revascularization Program is to increase awareness and understanding of moyamoya and other cerebrovascular diseases (eg, Cerebral Revascularization and Moyamoya Registry). Please contact us at 717-531-0895 or firstname.lastname@example.org to learn more about our research and education efforts.
Visit StudyFinder for information on our current clinical trials.